Macroscopic hematuria Urological and Genital Diseases
Conditions
Interventions
Intervention clusters: nurse-led rapid access clinic and the use of diagnostic test (IB-test).
Control clusters: standardized care pathways
Patients are included prior to diagnostic cystoscopy for m
Sponsors
Skåne University Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female 2. Hematuria referral 3. Aged 50 years or older
Exclusion criteria
Exclusion criteria: 1. Age below 50 years 2. Lack of informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time from hematuria to cystoscopy/bladder cancer diagnosis measured using patient records. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patient reported experience measures (PREM): urography or cystoscopy PREM - Validated national questionnaire for patient-reported outcomes - filled in by patient after cystoscopy 2. Cost effectiveness measured using EQ-5D-5L and direct costs extracted from patient charts at the end of the study 3. Sensitivity and specificity for the IB-test to detect bladder cancer measured by comparing the IB test result to the actual outcome (positive or negative) at the end of the study | — |
Countries
Sweden
Outcome results
None listed